See All Slides - tctmd.com

Slides

Presentation TCT 2013

A Surgeon Is the Best Person to Determine Risk Assessment for TAVR!

Presenter: A. Pieter Kappetein

October 31, 2013

Presentation TCT 2013

Current Landscape, Opportunities and Challenges for Drug-Coated Balloon Technologies

Presenter: Juan Granada

October 31, 2013

Presentation TCT 2013

Absolutely Required - Now and in the Future!

Presenter: Mathew Williams

October 31, 2013

Presentation TCT 2013

Improving Quality and Efficiency in Clinical Trials: The Clinical Trials Transformation Initiative (CTTI)

Presenter: Bray Patrick-Lake

October 30, 2013

Presentation TCT 2013

Imaging Coronary Plaques: Best of EHJ

Presenter: Lorenz Raber

October 30, 2013

Presentation TCT 2013

Case Presentation #1: Iatrogenic Aortic Dissection-Complicated Course

Presenter: David Kurz

October 30, 2013

Presentation TCT 2013

Update on Management of Acute Uncomplicated Type B Aortic Dissection

Presenter: Christoph Nienaber

October 30, 2013

Presentation TCT 2013

Neurological Complications of TEVAR: Prevention and Management

Presenter: Michael Dake

October 30, 2013

Presentation TCT 2013

TAVR Accessory Devices: How Much Clinical Trial Rigor and What Are Appropriate Surrogate Endpoints?

Presenter: Alexandra Lansky

October 30, 2013

Presentation TCT 2013

Motion: There is No Role for Thrombolysis in Modern STEMI Management - For: All Patients Should Receive Primary Angioplasty!

Presenter: Cindy Grines

October 30, 2013

Advertisement

Slides

A Surgeon Is the Best Person to Determine Risk Assessment for TAVR!

Current Landscape, Opportunities and Challenges for Drug-Coated Balloon Technologies

Absolutely Required - Now and in the Future!

Improving Quality and Efficiency in Clinical Trials: The Clinical Trials Transformation Initiative (CTTI)

Imaging Coronary Plaques: Best of EHJ

Case Presentation #1: Iatrogenic Aortic Dissection-Complicated Course

Update on Management of Acute Uncomplicated Type B Aortic Dissection

Neurological Complications of TEVAR: Prevention and Management

TAVR Accessory Devices: How Much Clinical Trial Rigor and What Are Appropriate Surrogate Endpoints?

Motion: There is No Role for Thrombolysis in Modern STEMI Management - For: All Patients Should Receive Primary Angioplasty!

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content